Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

High-Throughput Compound Profiling Using Tecan Instrumentation

Tracy Worzella and Brad Larson
Promega Corporation
Publication Date: 2006


Combining high-throughput, homogeneous screening assays and integrated automated instrumentation allows researchers to efficiently profile compounds that may be potential drugs. To assess if the compounds of interest are worth pursuing, multiple assays are required to examine cell responses (e.g., apoptosis) and effects on nontarget biochemical systems such as cytochrome P450 and kinases. Knowing how the drug affects its target and becoming aware of any potential cytotoxicity and other off-target effects are essential in the drug discovery decision-making process.

Promega Notes 92, 4–6.